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SECURITY
§ African swine fever causes up to 100% fatality in 
pigs, leading to severe economic losses to the pig 
sector.
§ There is currently no commercially available
vaccine
§ Tackling ASF through the development of a
vaccine will improve the livelihoods of small-
holder pig farmers in SSA
Accelerating African Swine Fever 
Virus (ASFV) Vaccine Development 
via CRISPR-Cas9 and Synthetic 
Biology Technologies
Context
• ASFV is a lethal viral disease of pigs, endemic in 
most SSA countries and continues to expand 
into new territories in Europe and Asia
• ASFV is a major economic threat to global pig 
industry.
• Currently, there's no vaccine against ASFV.
• Previous approaches to generate attenuated 
ASFV vaccine was cumbersome and largely 
inefficient
• Urgent need to deploy enabling technologies to 
generate efficacious vaccine to combat this 
disease.
Our innovative approach
• We are employing the highly efficient 
CRISPR/Cas9 and innovative synthetic biology 
approaches to fast-track rational development 
of ASFV vaccine candidates.
Future steps 
• Scale up generation of more live-attenuated 
ASFV vaccine candidates.
• Post-2021 potential: wider applicability 
and relevance: these versatile technologies 
can be applied in generating vaccines for 
other pathogens; bacteria and parasites, etc.
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Outcomes
• Successfully established CRISPR/Cas9 system 
for editing ASFV genome.
• Synthetic Biology Platform for rapid 
modification of ASFV genome.
• Generated 6 ASFV live-attenuated vaccine 
candidates due to be tested in pigs.
• One manuscript under preparation.
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